Inventiva (IVA) Gains from Investment Securities (2021 - 2024)
Inventiva's (IVA) quarterly Gains from Investment Securities came in at -$9.2 million in Q2 2024, down 364.75% quarter-over-quarter from $3.5 million in Q2 2021.
Inventiva (IVA) Gains from Investment Securities (2021 - 2024) Analysis & Trends
Inventiva's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$9.2 million for Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Inventiva | 854.62 Mn | 854.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -9.16 Mn |
| Jun 30, 2024 | -9.16 Mn |
| Jun 30, 2021 | 3.46 Mn |
| Jun 30, 2021 | 3.46 Mn |
| Mar 31, 2021 | -2.68 Mn |
| Mar 31, 2021 | -2.68 Mn |